Atlas FDA

MYNX CONTROL™ Venous Vascular Closure Device (VCD) 6F-12F

FDA premarket approval P040044/S097 · decided 2024-06-27

Approval details

PMA number
P040044
Supplement
S097
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
MYNX CONTROL™ Venous Vascular Closure Device (VCD) 6F-12F
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2023-11-30
Decision date
2024-06-27
Days to decision
210 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
Approval for the MYNX CONTROL™ Venous Vascular Closure Device (VCD) 6F-12F for expanding the indications to include venous multiple access closure.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.